CL
PFE icon

Croft-Leominster’s Pfizer PFE Stock Holding History

Croft-Leominster’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$605K Sell
17,607
-84,437
-83% -$2.88M 0.57% 51
2017
Q3 		$3.46M Sell
102,044
-1,786
-2% -$57.4K 0.82% 49
2017
Q2 		$3.31M Buy
103,830
+107
+0.1% +$3.37K 0.78% 53
2017
Q1 		$3.37M Buy
+103,723
New +$3.27M 0.8% 48
2016
Q4 		– Sell
-108,148
Closed -$3.3M – 50
2016
Q3 		$3.48M Sell
108,148
-108,286
-50% -$3.62M 0.86% 48
2016
Q2 		$7.23M Sell
216,434
-4,090
-2% -$131K 1.63% 15
2016
Q1 		$6.2M Sell
220,524
-10,608
-5% -$303K 1.41% 23
2015
Q4 		$7.08M Sell
231,132
-5,138
-2% -$162K 1.52% 16
2015
Q3 		$7.04M Sell
236,270
-12,596
-5% -$404K 1.63% 16
2015
Q2 		$7.92M Buy
248,866
+4,999
+2% +$163K 1.53% 16
2015
Q1 		$8.05M Sell
243,867
-3,643
-1% -$116K 1.48% 16
2014
Q4 		$7.32M Sell
247,510
-3,258
-1% -$93.4K 1.28% 24
2014
Q3 		$7.04M Buy
250,768
+594
+0.2% +$16.7K 1.24% 25
2014
Q2 		$7.04M Sell
250,174
-29,163
-10% -$831K 1.19% 28
2014
Q1 		$8.51M Sell
279,337
-35,117
-11% -$1.05M 1.35% 22
2013
Q4 		$9.14M Sell
314,454
-22,034
-7% -$641K 1.38% 21
2013
Q3 		$9.17M Sell
336,488
-104,260
-24% -$2.84M 1.5% 14
2013
Q2 		$11.7M Buy
+440,748
New +$12.2M 1.72% 14

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Croft-Leominster's PFE Position: Q4 2017 in Review

Croft-Leominster reduced its Pfizer (PFE) stake by 83% in Q4 2017, selling an estimated $2.88M and leaving 17,607 shares worth $605K. The position accounts for 0.57% of the portfolio, ranked #51.

Croft-Leominster first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $11.7M in Q2 2013. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Croft-Leominster held 17,607 shares of Pfizer worth $605K as of Q4 2017.
  • Croft-Leominster sold 84,437 Pfizer shares in Q4 2017, an estimated $2.88M.
  • Pfizer made up 0.57% of Croft-Leominster's portfolio in Q4 2017, its #51 holding.
  • Croft-Leominster first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
  • Croft-Leominster's Pfizer position peaked at $11.7M in Q2 2013.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Croft-Leominster's 13F filing for Q4 2017, filed 6 Mar 2018.